Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FG1MU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,789
Award facts
- Contract value 100% obligated
- $11,788.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a competitively-awarded delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count unit dose) valued at $11,788.91. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with a completion deadline of November 25, 2025. The contract employs firm fixed-price pricing with no set-aside designation, reflecting open competitive procurement standards.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, with an extensive portfolio covering brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. As a major healthcare solutions provider, the company fulfills pharmaceutical needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its DLA Troop Support Medical contract, which enables flexible supply of critical medical commodities to support military healthcare programs worldwide. This delivery order for RINVOQ ER, a JAK inhibitor typically used in rheumatologic disease management, demonstrates the company's continued role in supplying specialized pharmaceutical products to support federal healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FG1MU?
SPE2DR26FG1MU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26FG1MU worth?
The government has obligated $11,789 on SPE2DR26FG1MU.
Is contract SPE2DR26FG1MU an order under another contract?
Yes. SPE2DR26FG1MU is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG1MU competed?
The extent of competition for SPE2DR26FG1MU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award